z-logo
open-access-imgOpen Access
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome
Author(s) -
Mark Consugar,
Wai Chong Wong,
Patrick A. Lundquist,
Sandro Rossetti,
Vickie Kubly,
Denise L. Walker,
Laureano J. Rangel,
Richard Aspinwall,
W. Patrick Niaudet,
Seza Özen,
Albert David,
Milen Velinov,
Eric J. Bergstralh,
Kyongtae T. Bae,
Arlene B. Chapman,
Lisa M. GuayWoodford,
Jared J. Grantham,
Vicente E. Torres,
Julian R. Sampson,
Brian D Dawson,
Peter C. Harris,
for the CRISP Consortium
Publication year - 2008
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2008.485
Subject(s) - pkd1 , autosomal dominant polycystic kidney disease , genetics , biology , pseudogene , polycystic kidney disease , gene duplication , mutation , multiplex ligation dependent probe amplification , gene , microbiology and biotechnology , genome , exon , kidney
Large DNA rearrangements account for about 8% of disease mutations and are more common in duplicated genomic regions, where they are difficult to detect. Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2. PKD1 is located in an intrachromosomally duplicated region. A tuberous sclerosis gene, TSC2, lies immediately adjacent to PKD1 and large deletions can result in the PKD1/TSC2 contiguous gene deletion syndrome. To rapidly identify large rearrangements, a multiplex ligation-dependent probe amplification assay was developed employing base-pair differences between PKD1 and the six pseudogenes to generate PKD1-specific probes. All changes in a set of 25 previously defined deletions in PKD1, PKD2 and PKD1/TSC2 were detected by this assay and we also found 14 new mutations at these loci. About 4% of the ADPKD patients in the CRISP study were found to have gross rearrangements, and these accounted for about a third of base-pair mutation negative families. Sensitivity of the assay showed that about 40% of PKD1/TSC contiguous gene deletion syndrome families contained mosaic cases. Characterization of a family found to be mosaic for a PKD1 deletion is discussed here to illustrate family risk and donor selection considerations. Our assay improves detection levels and the reliability of molecular testing of patients with ADPKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom